We are going to exhibit at the 16th Annual Meeting of the Japan society of Clinical Trials and Research in Pacifico Yokohama Conference Center. Please come to visit us! Event Details Dates: Friday, February 28 to Saturday, March 1, 2025 Venue: Booth No.35, 301-302 Conference Center 3F, Pacifico Yokohama Conference Website: https://pub.confit.atlas.jp/ja/event/jsctr16
Consecutive Selection for the “2024 China Life Science Service Enterprise Brand Top 100” ClinChoice Group has been honored with a consecutive selection for the prestigious “2024 China Life Science Service Enterprise Brand Top 100.” Leveraging its outstanding service capabilities and brand influence, ClinChoice has firmly secured this recognition once again. The ranking evaluates enterprises comprehensively […]
ClinChoice recently hosted the “ClinChoice Seminar,” which attracted a large number of attendees from various Pharmaceutical companies across Japan. The seminar focused on “Clinical Pharmaceuticals in the Chinese Market, including Regulatory Affairs in China and the APAC Region,” drawing significant interest and receiving highly positive feedback from participants. One of the highlights was a session […]
We were honored to participate in the SAS User Conference 2024, held from September 18 to September 19, 2024, at the Yayoi Auditorium, University of Tokyo. The SAS User Conference is a premier event that brings together experts, researchers, healthcare professionals, and industry leaders to share the latest developments in using SAS, present case studies, […]
SHANGHAI, PHILADELPHIA and SINGAPORE, Jan. 11, 2024 /PRNewswire/ — ClinChoice, a leading global Contract Research Organization (CRO), today announced expanding its global footprint with the acquisition of CSI Medical Research (CSI). CSI is a regional clinical CRO with professional staff and partners located across Southeast Asia (SEA), Australia and New Zealand (ANZ), to provide innovative […]
Recently, The Asset, an authoritative international financial media, announced the list of winners of the 2024 Triple A Treasuries Awards, and ClinChoice was honored with the “Best Liquidity Funds Management Solution in Healthcare” for its excellent financial management system. This not only highlights our leading position in the healthcare sector, but also illustrates the continuous […]
PHILADELPHIA, SHANGHAI and VERONA, Italy, March 1, 2023 /PRNewswire/ — ClinChoice Medical Development is pleased to announce its acquisition of CROMSOURCE S.r.l., an ISO-certified full-service contract research organization with its corporate headquarters in Verona, Italy and its US headquarters in Cary, NC. CROMSOURCE has operational subsidiaries in the US and seven countries throughout Western and […]
With the booming development of global biopharmaceutical field, the annual meeting of Drug Information International (DIA) has become an important platform for communication, cooperation, and innovation in the industry. ClinChoice, as a leader in the field of CRO, will attend this meeting. We will display our innovative achievements and comprehensive strength in Hall C, M05. […]
ClinChoice Co., Ltd. has been awarded the second stage of the “Eruboshi Certification,” recognizing its efforts in promoting gender equality and supporting women’s advancement in the workplace. The “Eruboshi Certification” is based on the Act on Promotion of Women’s Participation and Advancement in the Workplace, awarded to companies that meet certain standards and demonstrate excellence […]